Wacker Chemie AG
XMUN:WCH

Watchlist Manager
Wacker Chemie AG Logo
Wacker Chemie AG
XMUN:WCH
Watchlist
Price: 97.3 EUR -6.89%
Market Cap: €7.3B

Wacker Chemie AG
Investor Relations

Wacker Chemie AG is a German chemicals company that makes specialty materials used in everyday industrial products. Its core businesses include silicones, polymer binders, and high-purity polysilicon. These materials are sold to other manufacturers, not to consumers, and they end up in products such as construction materials, coatings, sealants, electronics, solar equipment, personal care items, and medical products. The company mainly sells to industrial customers, including chemical distributors, construction suppliers, electronics makers, automotive suppliers, solar companies, and manufacturers of paints, adhesives, and consumer goods. It makes money by producing and selling these materials under long-term industrial relationships, with prices tied to raw materials, product grade, and customer demand. Some of its business is more cyclical than consumer chemicals because it depends on manufacturing activity and, for polysilicon, the solar and semiconductor markets. What makes Wacker different is that it sits in the middle of several specialized supply chains where product quality and technical know-how matter a lot. Its silicones and polymers are tailored ingredients that other companies mix into finished products, while its polysilicon is a critical input for chips and solar cells. That mix gives Wacker a role as a technical materials supplier rather than a brand-focused consumer company.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2026
Call Date
Apr 29, 2026
AI Summary
Q1 2026

Solid start: Wacker reported first-quarter sales of EUR 1.41 billion, down 5% year over year, but EBITDA rose 45% to EUR 173 million thanks to the PACE cost program and some customer order pull-forward.

Guidance nudged up: The company kept full-year EBITDA guidance at EUR 550 million to EUR 700 million, but raised its sales outlook to high single-digit growth as it plans to pass through higher raw material costs with price increases.

Cost savings: Management said PACE is already delivering savings, with about EUR 40 million realized in Q1, and reiterated its goal of more than EUR 300 million in annual savings by 2028 and EUR 200 million in 2026.

Demand remains weak: Despite better-than-expected Q1 order patterns, management stressed that many end markets are still weak, visibility is short, and risks remain elevated because of the Middle East conflict and trade policy uncertainty.

Segment mix: Silicones, polymers, and polysilicon all benefited in different ways, while BioSolutions was helped by contract timing; management expects Q2 to be weaker than Q1 as the pre-buying effect fades.

Key Financials
Sales
EUR 1.41 billion
EBITDA
EUR 173 million
EBIT
EUR 52 million
Net income
EUR 15 million
Earnings per share
EUR 0.21
Equity
EUR 3.82 billion
Liquidity
EUR 1.44 billion
Net working capital
up EUR 119 million
Net debt
EUR 964 million
CapEx
around EUR 300 million
PACE savings
roughly EUR 40 million
Silicones sales
EUR 708 million
Silicones EBITDA
EUR 117 million
Polymers sales
EUR 333 million
Polymers EBITDA
EUR 166 million
BioSolutions sales
EUR 100 million
BioSolutions EBITDA
EUR 13 million
Polysilicon sales
EUR 226 million
Polysilicon EBITDA
EUR 23 million
Earnings Call Recording
Other Earnings Calls

Management

Ms. Angela Worl
Head of Human Resource, Personnel Director & Member of Executive Board
No Bio Available
Dr. Christian Kirsten
Member of the Executive Board
No Bio Available
Mr. Rainald Hagenhues
Head of Corproate Accounting & Tax
No Bio Available
Mr. Joerg Hoffmann C.F.A.
Head of Investor Relations
No Bio Available
Mr. Jörg Hettmann
Head of Corporate Communications
No Bio Available
Dr. Thomas Koini
Head of Sales & Distribution
No Bio Available
Dr. Fridolin Stary
Head of Corporate Research & Development
No Bio Available
Mr. Joerg Krey
Chief Digital Officer of Operations
No Bio Available
Dr. Karl-Heinz Rimböck
Head of Intellectual Property
No Bio Available
Ms. Susanne Leonhartsberger
President of Biosolutions
No Bio Available

Contacts

Address
BAYERN
Muenchen
Hanns-Seidel-Platz 4
Contacts
+498962790.0
www.wacker.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett